Site icon Syngene International Ltd

Powering up antibody-drug conjugates with PROTACS

Read this White Paper on the ADC alternative that is capturing scientists’ imagination – antibody-linked PROTACs and the impact it could have in oncology, neurology, virology, and agriculture.

Exit mobile version